Epigenetics and muscle dysfunction in chronic obstructive pulmonary disease

Translational Research

Volumn 165, Issue 1, 2015, Pages 61-73

  Barreiro, Esther ^a,b   Gea, Joaquim ^a,b  

^a HOSPITAL DEL MAR   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; HISTONE;

BREATHING MUSCLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE EXACERBATION; DISEASE SEVERITY; DNA HISTONE INTERACTION; DNA METHYLATION; ENVIRONMENTAL FACTOR; EPIGENETICS; EXERCISE; GENE CONTROL; HISTONE ACETYLATION; HISTONE METHYLATION; HUMAN; LEG MUSCLE; MUSCLE DEVELOPMENT; MUSCLE DISEASE; QUALITY OF LIFE; REVIEW; SKELETAL MUSCLE; VASTUS LATERALIS MUSCLE; ADAPTATION; ANIMAL; GENETIC EPIGENESIS; GENETICS; METABOLISM; PATHOPHYSIOLOGY; TRANSLATIONAL RESEARCH;

ADAPTATION, PHYSIOLOGICAL; ANIMALS; DNA METHYLATION; EPIGENESIS, GENETIC; HISTONES; HUMANS; MICRORNAS; MUSCLE DEVELOPMENT; MUSCLE, SKELETAL; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; TRANSLATIONAL MEDICAL RESEARCH;

EID: 84919860371     PISSN: 19315244     EISSN: 18781810     Source Type: Journal    
DOI: 10.1016/j.trsl.2014.04.006     Document Type: Review

References (95)

1. J. Vestbo, S.S. Hurd, and A.G. Agusti Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary Am J Respir Crit Care Med 187 2013 347 365
2. M. Miravitlles, J.J. Soler-Cataluna, and M. Calle Spanish COPD Guidelines (GesEPOC): pharmacological treatment of stable COPD. Spanish Society of Pulmonology and Thoracic Surgery Arch Bronconeumol 48 2012 247 257
3. M. Miravitlles, M. Calle, and J.J. Soler-Cataluna Clinical phenotypes of COPD: identification, definition and implications for guidelines Arch Bronconeumol 48 2012 86 98
4. N. Alamdari, Z. Aversa, E. Castillero, and P.O. Hasselgren Acetylation and deacetylation - novel factors in muscle wasting Metabolism 62 2013 1 11
5. A. Lewis, J. Riddoch-Contreras, and S.A. Natanek Downregulation of the serum response factor/miR-1 axis in the quadriceps of patients with COPD Thorax 67 2012 26 34
6. R. Gosselink, T. Troosters, and M. Decramer Peripheral muscle weakness contributes to exercise limitation in COPD Am J Respir Crit Care Med 153 1996 976 980
7. J.M. Seymour, M.A. Spruit, and N.S. Hopkinson The prevalence of quadriceps weakness in COPD and the relationship with disease severity Eur Respir J 36 2010 81 88
8. K. Marquis, R. Debigare, and Y. Lacasse Midthigh muscle cross-sectional area is a better predictor of mortality than body mass index in patients with chronic obstructive pulmonary disease Am J Respir Crit Care Med 166 2002 809 813
9. E.B. Swallow, D. Reyes, and N.S. Hopkinson Quadriceps strength predicts mortality in patients with moderate to severe chronic obstructive pulmonary disease Thorax 62 2007 115 120
10. S. Levine, M.H. Bashir, T.L. Clanton, S.K. Powers, and S. Singhal COPD elicits remodeling of the diaphragm and vastus lateralis muscles in humans J Appl Physiol 114 2013 1235 1245
11. J. Gea, A. Agusti, and J. Roca Pathophysiology of muscle dysfunction in COPD J Appl Physiol 114 2013 1222 1234
12. M.J. Mador, and E. Bozkanat Skeletal muscle dysfunction in chronic obstructive pulmonary disease Respir Res 2 2001 216 224
13. E. Barreiro, A.M. Schols, and M. Polkey Cytokine profile in quadriceps muscles of patients with severe COPD Thorax 63 2008 100 107
14. C. Fermoselle, R. Rabinovich, and P. Ausin Does oxidative stress modulate limb muscle atrophy in severe COPD patients? Eur Respir J 40 2012 851 862
15. D. Testelmans, T. Crul, and K. Maes Atrophy and hypertrophy signalling in the diaphragm of patients with COPD Eur Respir J 35 2010 549 556
16. J. Marin-Corral, J. Minguella, A.L. Ramirez-Sarmiento, S.N. Hussain, J. Gea, and E. Barreiro Oxidised proteins and superoxide anion production in the diaphragm of severe COPD patients Eur Respir J 33 2009 1309 1319
17. C.A. Ottenheijm, L.M. Heunks, and Y.P. Li Activation of the ubiquitin-proteasome pathway in the diaphragm in chronic obstructive pulmonary disease Am J Respir Crit Care Med 174 2006 997 1002
18. C.A. Ottenheijm, M.W. Lawlor, G.J. Stienen, H. Granzier, and A.H. Beggs Changes in cross-bridge cycling underlie muscle weakness in patients with tropomyosin 3-based myopathy Hum Mol Genet 20 2011 2015 2025
19. E. Barreiro, B. de la Puente, and J. Minguella Oxidative stress and respiratory muscle dysfunction in severe chronic obstructive pulmonary disease Am J Respir Crit Care Med 171 2005 1116 1124
20. E. Barreiro, J.B. Galdiz, M. Marinan, F.J. Alvarez, S.N. Hussain, and J. Gea Respiratory loading intensity and diaphragm oxidative stress: N-acetyl-cysteine effects J Appl Physiol 100 2006 555 563
21. E. Barreiro, R. Rabinovich, J. Marin-Corral, J.A. Barbera, J. Gea, and J. Roca Chronic endurance exercise induces quadriceps nitrosative stress in patients with severe COPD Thorax 64 2009 13 19
22. E. Barreiro, V.I. Peinado, and J.B. Galdiz Cigarette smoke-induced oxidative stress: a role in chronic obstructive pulmonary disease skeletal muscle dysfunction Am J Respir Crit Care Med 182 2010 477 488
23. E. Barreiro, D. Ferrer, and F. Sanchez Inflammatory cells and apoptosis in respiratory and limb muscles of patients with COPD J Appl Physiol 111 2011 808 817
24. E. Barreiro, and J.I. Sznajder Epigenetic regulation of muscle phenotype and adaptation: a potential role in COPD muscle dysfunction J Appl Physiol 114 2013 1263 1272
25. R. Casaburi, S. Bhasin, and L. Cosentino Effects of testosterone and resistance training in men with chronic obstructive pulmonary disease Am J Respir Crit Care Med 170 2004 870 878
26. C. Coronell, M. Orozco-Levi, R. Mendez, A. Ramirez-Sarmiento, J.B. Galdiz, and J. Gea Relevance of assessing quadriceps endurance in patients with COPD Eur Respir J 24 2004 129 136
27. E.C. Creutzberg, E.F. Wouters, R. Mostert, C.A. Weling-Scheepers, and A.M. Schols Efficacy of nutritional supplementation therapy in depleted patients with chronic obstructive pulmonary disease Nutrition 19 2003 120 127
28. E.C. Creutzberg, E.F. Wouters, R. Mostert, R.J. Pluymers, and A.M. Schols A role for anabolic steroids in the rehabilitation of patients with COPD? A double-blind, placebo-controlled, randomized trial Chest 124 2003 1733 1742
29. T. Crul, M.A. Spruit, and G. Gayan-Ramirez Markers of inflammation and disuse in vastus lateralis of chronic obstructive pulmonary disease patients Eur J Clin Invest 37 2007 897 904
30. T. Crul, D. Testelmans, and M.A. Spruit Gene expression profiling in vastus lateralis muscle during an acute exacerbation of COPD Cell Physiol Biochem 25 2010 491 500
31. M. Decramer, V. de Bock, and R. Dom Functional and histologic picture of steroid-induced myopathy in chronic obstructive pulmonary disease Am J Respir Crit Care Med 153 6 Pt 1 1996 1958 1964
32. A. Donaldson, S.A. Natanek, and A. Lewis Increased skeletal muscle-specific microRNA in the blood of patients with COPD Thorax 68 2013 1140 1149
33. M. Doucet, A.P. Russell, and B. Leger Muscle atrophy and hypertrophy signaling in patients with chronic obstructive pulmonary disease Am J Respir Crit Care Med 176 2007 261 269
34. C. Fermoselle, F. Sanchez, and E. Barreiro Reduction of muscle mass mediated by myostatin in an experimental model of pulmonary emphysema Arch Bronconeumol 47 2011 590 598
35. G. Gayan-Ramirez, and M. Decramer Mechanisms of striated muscle dysfunction during acute exacerbations of COPD J Appl Physiol 114 2013 1291 1299
36. H.R. Gosker, M.P. Zeegers, E.F. Wouters, and A.M. Schols Muscle fibre type shifting in the vastus lateralis of patients with COPD is associated with disease severity: a systematic review and meta-analysis Thorax 62 2007 944 949
37. L. Laviolette, L.C. Lands, and N. Dauletbaev Combined effect of dietary supplementation with pressurized whey and exercise training in chronic obstructive pulmonary disease: a randomized, controlled, double-blind pilot study J Med Food 13 2010 589 598
38. M. Montes de Oca, and B.R. Celli Peripheral muscles in COPD: deconditioning or myopathy? Arch Bronconeumol 37 2001 82 87
39. S.A. Natanek, J. Riddoch-Contreras, and G.S. Marsh Yin Yang 1 expression and localisation in quadriceps muscle in COPD Arch Bronconeumol 47 2011 296 302
40. L. Puente-Maestu, J. Perez-Parra, and R. Godoy Abnormal transition pore kinetics and cytochrome C release in muscle mitochondria of patients with chronic obstructive pulmonary disease Am J Respir Cell Mol Biol 40 2009 746 750
41. L. Puente-Maestu, J. Perez-Parra, and R. Godoy Abnormal mitochondrial function in locomotor and respiratory muscles of COPD patients Eur Respir J 33 2009 1045 1052
42. L. Puente-Maestu, A. Lazaro, and A. Tejedor Effects of exercise on mitochondrial DNA content in skeletal muscle of patients with COPD Thorax 66 2011 121 127
43. L. Puente-Maestu, A. Tejedor, and A. Lazaro Site of mitochondrial reactive oxygen species production in skeletal muscle of chronic obstructive pulmonary disease and its relationship with exercise oxidative stress Am J Respir Cell Mol Biol 47 2012 358 362
44. L. Puente-Maestu, A. Lazaro, and B. Humanes Metabolic derangements in COPD muscle dysfunction J Appl Physiol 114 2013 1282 1290
45. D.A. Rodriguez, S. Kalko, and E. Puig-Vilanova Muscle and blood redox status after exercise training in severe COPD patients Free Radic Biol Med 52 2012 88 94
46. E.B. Swallow, H.R. Gosker, and K.A. Ward A novel technique for nonvolitional assessment of quadriceps muscle endurance in humans J Appl Physiol 103 2007 739 746
47. I. Vogiatzis, G. Terzis, and S. Nanas Skeletal muscle adaptations to interval training in patients with advanced COPD Chest 128 2005 3838 3845
48. I. Vogiatzis, G. Stratakos, and D.C. Simoes Effects of rehabilitative exercise on peripheral muscle TNFalpha, IL-6, IGF-I and MyoD expression in patients with COPD Thorax 62 2007 950 956
49. I. Vogiatzis, D.C. Simoes, and G. Stratakos Effect of pulmonary rehabilitation on muscle remodelling in cachectic patients with COPD Eur Respir J 36 2010 301 310
50. I. Vogiatzis, G. Terzis, and G. Stratakos Effect of pulmonary rehabilitation on peripheral muscle fiber remodeling in patients with COPD in GOLD stages II to IV Chest 140 2011 744 752
51. F. Whittom, J. Jobin, and P.M. Simard Histochemical and morphological characteristics of the vastus lateralis muscle in patients with chronic obstructive pulmonary disease Med Sci Sports Exerc 30 1998 1467 1474
52. K. Baar Epigenetic control of skeletal muscle fibre type Acta Physiol (Oxf) 199 2010 477 487
53. S. Sharma, T.K. Kelly, and P.A. Jones Epigenetics in cancer Carcinogenesis 31 2010 27 36
54. M.W. Lawless, K.J. O'Byrne, and S.G. Gray Targeting oxidative stress in cancer Expert Opin Ther Targets 14 2010 1225 1245
55. L.F. Chen, and W.C. Greene Regulation of distinct biological activities of the NF-kappaB transcription factor complex by acetylation J Mol Med (Berl) 81 2003 549 557
56. K. Sadoul, C. Boyault, M. Pabion, and S. Khochbin Regulation of protein turnover by acetyltransferases and deacetylases Biochimie 90 2008 306 312
57. D. Seigneurin-Berny, A. Verdel, and S. Curtet Identification of components of the murine histone deacetylase 6 complex: link between acetylation and ubiquitination signaling pathways Mol Cell Biol 21 2001 8035 8044
58. B.T. Scroggins, K. Robzyk, and D. Wang An acetylation site in the middle domain of Hsp90 regulates chaperone function Mol Cell 25 2007 151 159
59. S.A. Jacobs, and S. Khorasanizadeh Structure of HP1 chromodomain bound to a lysine 9-methylated histone H3 tail Science 295 2002 2080 2083
60. S.D. Taverna, S. Ilin, and R.S. Rogers Yng1 PHD finger binding to H3 trimethylated at K4 promotes NuA3 HAT activity at K14 of H3 and transcription at a subset of targeted ORFs Mol Cell 24 2006 785 796
61. J. Cote, and S. Richard Tudor domains bind symmetrical dimethylated arginines J Biol Chem 280 2005 28476 28483
62. Y. Huang, J. Fang, M.T. Bedford, Y. Zhang, and R.M. Xu Recognition of histone H3 lysine-4 methylation by the double tudor domain of JMJD2A Science 312 2006 748 751
63. M. Angulo, E. Lecuona, and J.I. Sznajder Role of MicroRNAs in lung disease Arch Bronconeumol 48 2012 325 330
64. Y. Lee, M. Kim, and J. Han MicroRNA genes are transcribed by RNA polymerase II EMBO J 23 2004 4051 4060
65. E. Perdiguero, P. Sousa-Victor, E. Ballestar, and P. Munoz-Canoves Epigenetic regulation of myogenesis Epigenetics 4 2009 541 550
66. Y. Kurihara, and Y. Watanabe Arabidopsis micro-RNA biogenesis through Dicer-like 1 protein functions Proc Natl Acad Sci U S A 101 2004 12753 12758
67. G. Hutvagner Small RNA asymmetry in RNAi: function in RISC assembly and gene regulation FEBS Lett 579 2005 5850 5857
68. J.R. O'Rourke, S.A. Georges, and H.R. Seay Essential role for Dicer during skeletal muscle development Dev Biol 311 2007 359 368
69. M.D. Deato, M.T. Marr, T. Sottero, C. Inouye, P. Hu, and R. Tjian MyoD targets TAF3/TRF3 to activate myogenin transcription Mol Cell 32 2008 96 105
70. N. Nakajima, T. Takahashi, and R. Kitamura MicroRNA-1 facilitates skeletal myogenic differentiation without affecting osteoblastic and adipogenic differentiation Biochem Biophys Res Commun 350 2006 1006 1012
71. M. Lucarelli, A. Fuso, R. Strom, and S. Scarpa The dynamics of myogenin site-specific demethylation is strongly correlated with its expression and with muscle differentiation J Biol Chem 276 2001 7500 7506
72. D. Palacios, and P.L. Puri The epigenetic network regulating muscle development and regeneration J Cell Physiol 207 2006 1 11
73. M.G. Guenther, S.S. Levine, L.A. Boyer, R. Jaenisch, and R.A. Young A chromatin landmark and transcription initiation at most promoters in human cells Cell 130 2007 77 88
74. S. Kuang, K. Kuroda, G.F. Le, and M.A. Rudnicki Asymmetric self-renewal and commitment of satellite stem cells in muscle Cell 129 2007 999 1010
75. I.W. McKinnell, J. Ishibashi, and G.F. Le Pax7 activates myogenic genes by recruitment of a histone methyltransferase complex Nat Cell Biol 10 2008 77 84
76. J.F. Chen, E.M. Mandel, and J.M. Thomson The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation Nat Genet 38 2006 228 233
77. L. Elia, R. Contu, and M. Quintavalle Reciprocal regulation of microRNA-1 and insulin-like growth factor-1 signal transduction cascade in cardiac and skeletal muscle in physiological and pathological conditions Circulation 120 2009 2377 2385
78. C. Anderson, H. Catoe, and R. Werner MIR-206 regulates connexin43 expression during skeletal muscle development Nucleic Acids Res 34 2006 5863 5871
79. B.K. Dey, J. Gagan, and A. Dutta miR-206 and -486 induce myoblast differentiation by downregulating Pax7 Mol Cell Biol 31 2011 203 214
80. C.G. Crist, D. Montarras, and G. Pallafacchina Muscle stem cell behavior is modified by microRNA-27 regulation of Pax3 expression Proc Natl Acad Sci U S A 106 2009 13383 13387
81. I. Naguibneva, M. Ameyar-Zazoua, and A. Polesskaya The microRNA miR-181 targets the homeobox protein Hox-A11 during mammalian myoblast differentiation Nat Cell Biol 8 2006 278 284
82. H. Wang, R. Garzon, and H. Sun NF-kappaB-YY1-miR-29 regulatory circuitry in skeletal myogenesis and rhabdomyosarcoma Cancer Cell 14 2008 369 381
83. L. Wang, L. Zhou, and P. Jiang Loss of miR-29 in myoblasts contributes to dystrophic muscle pathogenesis Mol Ther 20 2012 1222 1233
84. P.K. Rao, R.M. Kumar, M. Farkhondeh, S. Baskerville, and H.F. Lodish Myogenic factors that regulate expression of muscle-specific microRNAs Proc Natl Acad Sci U S A 103 2006 8721 8726
85. Y. Zhao, E. Samal, and D. Srivastava Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis Nature 436 2005 214 220
86. D.L. Allen, E.R. Bandstra, and B.C. Harrison Effects of spaceflight on murine skeletal muscle gene expression J Appl Physiol 106 2009 582 595
87. W. Aoi, Y. Naito, and K. Mizushima The microRNA miR-696 regulates PGC-1{alpha} in mouse skeletal muscle in response to physical activity Am J Physiol Endocrinol Metab 298 2010 E799 E806
88. J.J. McCarthy, and K.A. Esser MicroRNA-1 and microRNA-133a expression are decreased during skeletal muscle hypertrophy J Appl Physiol 102 2007 306 313
89. D.L. Allen, J.N. Weber, L.K. Sycuro, and L.A. Leinwand Myocyte enhancer factor-2 and serum response factor binding elements regulate fast myosin heavy chain transcription in vivo J Biol Chem 280 2005 17126 17134
90. S. Ikeda, A. He, and S.W. Kong MicroRNA-1 negatively regulates expression of the hypertrophy-associated calmodulin and Mef2a genes Mol Cell Biol 29 2009 2193 2204
91. H. Wu, B. Rothermel, and S. Kanatous Activation of MEF2 by muscle activity is mediated through a calcineurin-dependent pathway EMBO J 20 2001 6414 6423
92. Y. Sun, Y. Ge, J. Drnevich, and J. Chen Mammalian target of rapamycin regulates miRNA-1 and follistatin in skeletal myogenesis J Cell Biol 189 2010 1157 1169
93. P.D. Ellis, K.M. Martin, C. Rickman, J.C. Metcalfe, and P.R. Kemp Increased actin polymerization reduces the inhibition of serum response factor activity by Yin Yang 1 Biochem J 364 Pt 2 2002 547 554
94. H. Wang, E. Hertlein, and N. Bakkar NF-kappaB regulation of YY1 inhibits skeletal myogenesis through transcriptional silencing of myofibrillar genes Mol Cell Biol 27 2007 4374 4387
95. N. Alamdari, I.J. Smith, Z. Aversa, and P.O. Hasselgren Sepsis and glucocorticoids upregulate p300 and downregulate HDAC6 expression and activity in skeletal muscle Am J Physiol Regul Integr Comp Physiol 299 2010 R509 R520